BEIJING – China this week approved both the country's first mRNA vaccine candidate and its first recombinant protein subunit vaccine to begin clinical trials to fight COVID-19. China National Biotec Group (CNBG)'s vaccine is also entering phase III trials in ...
from Google Alert - health https://ift.tt/2BeaqJ1
via IFTTT
0 comments:
Post a Comment